secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anixa Biosciences Inc (ANIX)
CIK:        0000715446
Form:       8-K
Filed at:   2022-04-15T23:59:59+00:00
Accession:  0001493152-22-010016
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Anixa promotes CFO/COO Michael Catelani to President; salary $434,512
---------------------------------------------------------------------

- Michael Catelani promoted to President effective April 14, 2022; retains roles as COO and CFO.
- Annual base salary increased to $434,512; granted option to purchase 100,000 shares at closing price.
- Stock option vests over 36 months, ten-year term, cashless exercise permitted.
- Dr. Amit Kumar steps down as President but remains Chairman and CEO; no related-party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/715446/000149315222010016/0001493152-22-010016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/715446/000149315222010016/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-010016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer